Pfizer CEO Albert Bourla told Fox News the company has a system in place to turn around a variant-specific jab within 95 days in the likelihood a vaccine-resistant COVID strain emerges, but experts warn that strategy will backfire.
On the “RFK, Jr. The Defender Podcast,” Dr. Peter McCullough discussed a new study by the Oxford University Clinical Research Group and how the Pfizer’s vaccine, at 17% to 42% efficacy, doesn't meet the regulatory standard of 50% efficacy for vaccines.
Delta Air Lines employees who are unvaccinated against COVID-19 will be charged an extra $200 a month for health insurance starting in November to help cover costs related to treatment of the disease, the CEO announced Wednesday.
As more celebrities and elected officials announce they are “really really sick” despite being fully vaccinated, questions swirl around whether the vaccines work and why the Centers of Disease Control and Prevention isn’t doing more to track breakthrough cases.